GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Laboratories Ltd (BOM:538964) » Definitions » E10

Mercury Laboratories (BOM:538964) E10 : ₹43.06 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mercury Laboratories E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mercury Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹9.940. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹43.06 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Mercury Laboratories's average E10 Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-11), Mercury Laboratories's current stock price is ₹806.10. Mercury Laboratories's E10 for the quarter that ended in Dec. 2024 was ₹43.06. Mercury Laboratories's Shiller PE Ratio of today is 18.72.

During the past 11 years, the highest Shiller PE Ratio of Mercury Laboratories was 27.40. The lowest was 18.16. And the median was 21.32.


Mercury Laboratories E10 Historical Data

The historical data trend for Mercury Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Laboratories E10 Chart

Mercury Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 43.41

Mercury Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.86 43.41 43.34 42.94 43.06

Competitive Comparison of Mercury Laboratories's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's Shiller PE Ratio falls into.


;
;

Mercury Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mercury Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=9.94/158.3229*158.3229
=9.940

Current CPI (Dec. 2024) = 158.3229.

Mercury Laboratories Quarterly Data

per share eps CPI Adj_EPS
201503 5.230 97.163 8.522
201506 8.470 99.841 13.431
201509 8.660 101.753 13.475
201512 27.890 102.901 42.911
201603 4.800 102.518 7.413
201606 7.850 105.961 11.729
201609 7.000 105.961 10.459
201612 2.970 105.196 4.470
201703 4.710 105.196 7.089
201706 -11.400 107.109 -16.851
201709 14.020 109.021 20.360
201712 10.950 109.404 15.846
201803 3.210 109.786 4.629
201806 6.770 111.317 9.629
201809 6.860 115.142 9.433
201812 8.170 115.142 11.234
201903 1.830 118.202 2.451
201906 8.320 120.880 10.897
201909 8.800 123.175 11.311
201912 12.730 126.235 15.966
202003 -2.950 124.705 -3.745
202006 8.010 127.000 9.986
202009 13.790 130.118 16.779
202012 16.960 130.889 20.515
202103 5.720 131.771 6.873
202106 10.380 134.084 12.256
202109 8.030 135.847 9.359
202112 4.340 138.161 4.973
202203 6.930 138.822 7.903
202206 12.190 142.347 13.558
202209 26.190 144.661 28.663
202212 5.050 145.763 5.485
202303 3.050 146.865 3.288
202306 8.330 150.280 8.776
202309 26.190 151.492 27.371
202312 10.300 152.924 10.664
202403 15.920 153.035 16.470
202406 2.850 155.789 2.896
202409 4.170 157.882 4.182
202412 9.940 158.323 9.940

Add all the adjusted EPS together and divide 10 will get our e10.


Mercury Laboratories  (BOM:538964) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mercury Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=806.10/43.06
=18.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Shiller P/E Ratio of Mercury Laboratories was 27.40. The lowest was 18.16. And the median was 21.32.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mercury Laboratories E10 Related Terms

Thank you for viewing the detailed overview of Mercury Laboratories's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Mercury Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and internationally, of which key revenue is derived from sales made in India.

Mercury Laboratories Headlines

No Headlines